Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.

Bermingham DP, Hardaway JA, Snarrenberg CL, Robinson SB, Folkes OM, Salimando GJ, Jinnah H, Blakely RD
Neurochem Int. 2016 98: 122-8

PMID: 26850478 · PMCID: PMC4969213 · DOI:10.1016/j.neuint.2016.01.008

MeSH Terms (14)

Animals Caenorhabditis elegans Caenorhabditis elegans Proteins Dopamine Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors Fluoxetine Gene Deletion Mutation Norepinephrine Plasma Membrane Transport Proteins Paralysis Plasmids Signal Transduction Swimming

Connections (1)

This publication is referenced by other Labnodes entities: